239 related articles for article (PubMed ID: 7084884)
1. Half-life time or clearance of indocyanine green in patients with liver disease.
Gilmore IT; Marigold JH; Thompson RP
Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
[TBL] [Abstract][Full Text] [Related]
2. Normal metabolism of morphine in cirrhosis.
Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
[TBL] [Abstract][Full Text] [Related]
3. [Hepatic clearance of 99mTc-p-butyl HIDA in liver diseases. Correlations with routine hematochemical parameters of liver function].
Custro N; De Francisci MC; Patanella I; Scafidi V; Indovina I
Minerva Med; 1984 Nov; 75(42):2527-32. PubMed ID: 6083507
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
[TBL] [Abstract][Full Text] [Related]
5. Colchicine clearance is impaired in alcoholic cirrhosis.
Leighton JA; Bay MK; Maldonado AL; Schenker S; Speeg KV
Hepatology; 1991 Dec; 14(6):1013-5. PubMed ID: 1959847
[TBL] [Abstract][Full Text] [Related]
6. The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
Klotz U; Avant GR; Hoyumpa A; Schenker S; Wilkinson GR
J Clin Invest; 1975 Feb; 55(2):347-59. PubMed ID: 1127104
[TBL] [Abstract][Full Text] [Related]
7. Cefoperazone pharmacokinetics in patients with liver cirrhosis: a predictive value of the ujoviridin test.
Saudek F; Morávek J; Modr Z
Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):82-7. PubMed ID: 2921099
[TBL] [Abstract][Full Text] [Related]
8. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of famotidine after intravenous administration in liver disease.
Ohnishi K
Am J Gastroenterol; 1991 Jan; 86(1):41-5. PubMed ID: 1986553
[TBL] [Abstract][Full Text] [Related]
10. [Different elimination velocity of indocyanine green in liver diseases of various severity].
Brügmann E
Z Gesamte Inn Med; 1973 Sep; 28(17):523-6. PubMed ID: 4767186
[No Abstract] [Full Text] [Related]
11. [Chromodiagnosis of the liver: interpretation of the elimination curve of indocyanine green dye (Wofaverdin)].
Seifert A; Ehrke D; Balzer H
Z Gesamte Inn Med; 1968 Sep; 23(17):527-31. PubMed ID: 5728034
[No Abstract] [Full Text] [Related]
12. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
Joeres R; Brachtel D; Gallenkamp H; Hofstetter G; Klinker H; Zilly W; Richter E
Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
[TBL] [Abstract][Full Text] [Related]
13. [Metabolism of hexobarbital in patients with acute hepatitis and cirrhosis (author's transl)].
Richter E; Gallenkamp H; Keller B; Brachtel D; Zilly W; Breimer DD
Z Gastroenterol; 1977 Jun; 15(6):381-8. PubMed ID: 888488
[TBL] [Abstract][Full Text] [Related]
14. Impaired elimination of meperidine in patients with liver disease.
McHorse TS; Klotz U; Wilkinson G; Schenker S
Trans Assoc Am Physicians; 1974; 87():281-7. PubMed ID: 4456737
[No Abstract] [Full Text] [Related]
15. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination.
Hepner GW; Vesell ES; Lipton A; Harvey HA; Wilkinson GR; Schenker S
J Lab Clin Med; 1977 Sep; 90(3):440-56. PubMed ID: 894100
[No Abstract] [Full Text] [Related]
16. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous measurement of effective hepatic blood flow and systemic circulation.
Hashimoto M; Watanabe G
Hepatogastroenterology; 2000; 47(36):1669-74. PubMed ID: 11149029
[TBL] [Abstract][Full Text] [Related]
18. Indocyanine green clearance--a liver function test.
Brügmann E; Töwe J
Mater Med Pol; 1974; 6(2):123-6. PubMed ID: 4431244
[No Abstract] [Full Text] [Related]
19. [Absorption of vofaverdin by the liver in circulatory insufficiency, chronic hepatitis and liver cirrhosis].
Fomichev VI
Klin Med (Mosk); 1973 Oct; 51(10):94-6. PubMed ID: 4787288
[No Abstract] [Full Text] [Related]
20. Hepatic metabolic function in patients receiving long-term methotrexate therapy: comparison with topically treated psoriatics, patient controls and cirrhotics.
Birnie GG; Fitzsimons CP; Czarnecki D; Cooke A; Scobie G; Brodie MJ
Hepatogastroenterology; 1985 Aug; 32(4):163-7. PubMed ID: 2865199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
